At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
Dialyzer with Endexodevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Open Label, Cross-over Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ in End-Stage Renal Disease (ESRD) Subjects
In Brief
A clinical study evaluating Dialyzer with Endexo for Chronic Kidney Diseases and Patient Requiring Heparin Free Dialysis Treatments. Completed, enrolled 16 participants across 2 sites.
Detailed Summary
This study will assess the safety and efficacy of heparin free hemodialysis (HD) performed with dialyzers with Endexo in adult end-stage renal disease (ESRD) subjects on thrice-weekly in-center HD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartNov 2020
Primary CompletionMay 2021
Study CompletionJun 2021
TodayJul 2026
First PostedAug 13, 2020
Enrollment StartNov 2, 2020
Primary CompletionMay 21, 2021
Study CompletionJun 16, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.9 years ago
Interventions
Dialyzer with Endexodevice
Sequence AB: Period 1 Circuit A (Five Visits: 1,2,3,4,5) Period 2 Circuit B (Five Visits: 9,10,11,12,13) Sequence BA: Period 1 Circuit B (Five Visits: 1,2,3,4,5) Period 2 Circuit A (Five Visits: 9,10,11,12,13)